Our Featured Experts

Jedd D. Wolchok, MD, PhD
Dr. Wolchok on Progress After Anti-PD-1 Monotherapy in Melanoma
Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Department of Medicine and Ludwig Center at Memorial Sloan Kettering Cancer Center, 2014 Giant of Cancer Care in Melanoma, discusses an ongoing clinical trial that will explore optimal treatments for patients with melanoma who fail on a PD-1 inhibitor as a single agent.
Maurie Markman, MD
Oncology Specialists
Publication Bottom Border
Border Publication